Table 2 Prevalence estimates for the MRSA in the elderly, according to the study characteristics and socio-demographic factors
Variable subgroup | Number of datasets | Number of elderlies screened (total) | Number of elderlies with MRSA | Pooled prevalence % (95% CI) |
|---|---|---|---|---|
Income | ||||
Upper middle | 16 | 12,071 | 2193 | 16.46 (10.79–23.05) |
High | 103 | 152,646 | 14,600 | 14.42 (11.98–17.04) |
HDI | ||||
High | 15 | 12,015 | 2185 | 16.60 (10.74–23.42) |
Very high | 104 | 152,702 | 14,608 | 14.42 (11.99–17.02) |
Type of setting | ||||
Long-term care facilities | 41 | 88,088 | 5069 | 16.29 (12.29–20.71) |
Nursing homes | 71 | 69,652 | 10,730 | 14.35 (11.50–17.44) |
Residential care homes | 7 | 6977 | 994 | 9.58 (3.62–17.93) |
Study design | ||||
Cross-sectional | 88 | 135,275 | 12,969 | 13.37 (10.68–16.30) |
Prospective cohort | 21 | 23,022 | 2756 | 17.90 (12.66–23.82) |
Case–control | 3 | 312 | 73 | 21.03 (3.67–46.99) |
RCT | 7 | 6108 | 995 | 20.15 (12.55–29.01) |
Publication year | ||||
Before 2000 | 14 | 3505 | 441 | 12.84 (9.24–16.93) |
2001–2010 | 27 | 33,541 | 4365 | 16.12 (11.43–21.44) |
2011–2022 | 78 | 127,671 | 11,987 | 14.53 (11.58–17.75) |
Risk of bias | ||||
Low | 68 | 151,473 | 14,489 | 13.06 (10.26–16.15) |
Moderate | 51 | 13,244 | 2304 | 17.11 (13.64–20.87) |